Showing 981 - 1,000 results of 107,331 for search '(( i de decrease ) OR ( 5 ((wt decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.68s Refine Results
  1. 981
  2. 982

    BA decreases DUB activity in PC cells. by Teresita Reiner (281437)

    Published 2013
    “…(<b>B</b>) DUB assay showed that BA treatment of LNCaP cells significantly decreased DUB activity at 24 and 48 h relative to control treated cells ( = 1) (*, <i>P</i><5×10<sup>−5</sup>). …”
  3. 983
  4. 984
  5. 985
  6. 986
  7. 987
  8. 988

    Spt5 protein is significantly decreased in <i>fog<sup>sk8</sup></i> embryos. by Keerthi Krishnan (269578)

    Published 2008
    “…(C–D) Whole mount immunofluorescence detection of Spt5 in WT and <i>fog<sup>sk8</sup></i> embryos at 24 hpf, showing overall decrease of Spt5 protein in <i>fog<sup>sk8</sup></i> embryos. …”
  9. 989
  10. 990
  11. 991
  12. 992

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
  13. 993
  14. 994
  15. 995

    Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

    Published 2012
    “…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”
  16. 996

    Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

    Published 2013
    “…<p>(A) The mean ΔBCD curves describe the difference between the treated and untreated lenses from all animals (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010402#s4" target="_blank">Methods and Materials</a>). …”
  17. 997
  18. 998
  19. 999
  20. 1000